Search - tctmd.com

Displaying 61 - 80 of 92

Sort: Relevancy | Date

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

L.A. McKeown

February 27, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Shelley Wood

January 04, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

News Conference News ESC 2016

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Shelley Wood

August 27, 2016

News Daily News

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

L.A. McKeown

April 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

Advertisement

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Guidelines for the Management of Valvular Heart Disease

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

TCTMD’s Top 10 Most Popular News and Features for 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

NSAIDs Plus Anticoagulants a Bad Combination

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content